100 Recruiting Studies Using Docetaxel
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Docetaxel
Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery
📍 University of Arizona Cancer Center-Orange Grove Campus — Tucson, Arizona
Stage III Sinonasal Squamous Cell Carcinoma AJCC v6 and v7
View Study & Checklist ➔Study to Evaluate Adverse Events and Change in Disease Activity When Intravenously (IV) Infused Livmoniplimab is Used in Combination With IV Infused Budigalimab in Adult Participants With Urothelial Carcinoma (UC)
📍 Highlands Oncology Group - Springdale /ID# 270290 — Springdale, Arkansas
Urothelial Carcinoma
View Study & Checklist ➔A Study to Evaluate Sacituzumab Tirumotecan (MK-2870) in Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-2870-015)
📍 Banner MD Anderson Cancer Center ( Site 0119) — Gilbert, Arizona
Gastroesophageal Cancer
View Study & Checklist ➔Study of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung Cancer
📍 Valley Medical Center Research — Renton, Washington
Non-Small Cell Lung Cancer
View Study & Checklist ➔Pembrolizumab With Chemotherapy for Poorly Chemo-responsive Thyroid and Salivary Gland Tumors
📍 University of Chicago Comprehensive Cancer Center — Chicago, Illinois
Thyroid Cancer
View Study & Checklist ➔Study of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer With or Without Actionable Genomic Alterations (TROPION-LUNG01)
📍 Ironwood Cancer and Research Center — Chandler, Arizona
Non-small Cell Lung Cancer
View Study & Checklist ➔Intravesical BCG vs GEMDOCE in NMIBC
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Non-muscle-invasive Bladder Cancer
View Study & Checklist ➔Study of Capivasertib + Docetaxel vs Placebo + Docetaxel as Treatment for Metastatic Castration Resistant Prostate Cancer (mCRPC)
📍 Research Site — Yuma, Arizona
Prostate Cancer
View Study & Checklist ➔A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)
📍 GSK Investigational Site — Goodyear, Arizona
Neoplasms
View Study & Checklist ➔First Strike, Second Strike Therapies for High Risk Metastatic Castration Sensitive Prostate Cancer
📍 Moffitt Cancer Center — Tampa, Florida
Prostate Cancer
View Study & Checklist ➔Assess Efficacy & Safety of Selumetinib in Combination With Docetaxel in Patients Receiving 2nd Line Treatment for v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Positive NSCLC
📍 Research Site — Aurora, Colorado
Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV
View Study & Checklist ➔Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung Cancer
📍 Veterans Administration Medical Center - Birmingham — Birmingham, Alabama
Metastatic Lung Non-Squamous Non-Small Cell Carcinoma
View Study & Checklist ➔177 LuPSMA-617 vs Docetaxel in Metastatic Castration Resistant and PSMA-Positive Prostate Cancer
📍 Tom Baker Cancer Centre — Calgary, Alberta
Prostate Cancer
View Study & Checklist ➔A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
Prostate Cancer
View Study & Checklist ➔A Study of Neoadjuvant Chemotherapy Plus Nivolumab Versus Neoadjuvant Chemotherapy Plus Placebo, Followed by Surgical Removal and Adjuvant Treatment With Nivolumab or Placebo for Participants With Surgically Removable Early Stage Non-small Cell Lung Cancer
📍 Local Institution - 0104 — Tampa, Florida
Carcinoma, Non-Small-Cell Lung
View Study & Checklist ➔REGN2810 Followed by Chemoimmunotherapy for Newly Metastatic Hormone-sensitive Prostate Cancer
📍 Columbia University Irving Medical Center — New York, New York
Prostate Cancer Metastatic
View Study & Checklist ➔Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Resectable Lung Non-Small Cell Carcinoma
View Study & Checklist ➔A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer)
📍 Arizona Clinical Research Center, Inc — Tucson, Arizona
Locally Advanced or Metastatic Breast Cancer
View Study & Checklist ➔Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers
📍 University of Arkansas for Medical Sciences — Little Rock, Arkansas
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
View Study & Checklist ➔Intravesical Gemcitabine and Docetaxel for BCG naïve Non-muscle Invasive Bladder Cancer
📍 Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center — Baltimore, Maryland
Urothelial Carcinoma Bladder
View Study & Checklist ➔Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer
📍 UCLA / Jonsson Comprehensive Cancer Center — Los Angeles, California
Anatomic Stage II Breast Cancer AJCC v8
View Study & Checklist ➔Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC
📍 Highlands Oncology Group — Springdale, Arkansas
Non Small Cell Lung Cancer
View Study & Checklist ➔Phase 3 Study of MRTX849 (Adagrasib) vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation
📍 Local Institution - 012-898 — Cerritos, California
Metastatic Non Small Cell Lung Cancer
View Study & Checklist ➔Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Mismatch Repair Deficient (dMMR) Advanced or Recurrent Endometrial Carcinoma (MK-3475-C93/KEYNOTE-C93/GOG-3064/ENGOT-en15)
📍 HonorHealth-USOR HonorHealth ( Site 8000) — Phoenix, Arizona
Endometrial Neoplasms
View Study & Checklist ➔Trametinib and Docetaxel in Treating Patients With Recurrent or Stage IV KRAS Mutation Positive Non-small Cell Lung Cancer
📍 Anchorage Associates in Radiation Medicine — Anchorage, Alaska
KRAS Gene Mutation
View Study & Checklist ➔Nivolumab + Docetaxel + ADT in mHSPC Patients With DDRD or Inflamed Tumors
📍 University of California, San Diego — La Jolla, California
Hormone Sensitive Prostate Cancer
View Study & Checklist ➔PROstate Cancer TReatment Optimization Via Analysis of Circulating Tumour DNA
📍 BC Cancer - Kelowna (Sindi Ahluwalia Hawkins Centre) — Kelowna, British Columbia
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
View Study & Checklist ➔Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053)
📍 University of Alabama - Birmingham ( Site 3061) — Birmingham, Alabama
Endometrial Neoplasms
View Study & Checklist ➔A Study of Anvumetostat in Participants With Advanced MTAP-null Solid Tumors (MTAPESTRY 101)
📍 City of Hope National Medical Center — Duarte, California
Advanced MTAP-null Solid Tumors
View Study & Checklist ➔A Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Participants With Advanced Urothelial Cancer and Selected Fibroblast Growth Factor Receptor (FGFR) Gene Aberrations
📍 Alaska Urological Institute dba Alaska Clinical Research Center — Anchorage, Alaska
Urothelial Cancer
View Study & Checklist ➔Therapeutic Effect of Cytoreductive Radical Prostatectomy in Men With Newly Diagnosed Metastatic Prostate Cancer
📍 City of Hope — Duarte, California
Stage IV Prostate Adenocarcinoma AJCC v7
View Study & Checklist ➔CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Anatomic Stage II Breast Cancer AJCC v8
View Study & Checklist ➔Phase 2 DoceRamPem for Patients With Metastatic or Recurrent NSCLC Who Progressed on Platinum-Doublet and PD-1/PD-L1 Blockade
📍 Grady Health System — Atlanta, Georgia
Metastatic Non-Small Lung Cell Cancer
View Study & Checklist ➔Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of Care Docetaxel in Non-Small Cell Lung Cancer (ABBIL1TY NSCLC-06)
📍 Arizona Blood and Cancer Specialists — Tucson, Arizona
PD-L1-positive, Locally Advanced (Unresectable Stage IIIB/C) or Metastatic NSCLC
View Study & Checklist ➔Study of Novel Treatment Combinations in Patients With Lung Cancer
📍 Arizona Oncology Associates,Substudy-02 — Tucson, Arizona
Lung Cancer
View Study & Checklist ➔Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004)
📍 UCLA Hematology/Oncology - Santa Monica ( Site 0023) — Los Angeles, California
Non-small Cell Lung Cancer (NSCLC)
View Study & Checklist ➔Study of Intravenous (IV) ABBV-637 Alone or in Combination With IV Docetaxel/Osimertinib to Assess Adverse Events and Change in Disease Activity in Adult Participants With Relapsed/Refractory (R/R) Solid Tumors
📍 Dana-Farber Cancer Institute /ID# 231209 — Boston, Massachusetts
Advanced Solid Tumors Cancer
View Study & Checklist ➔A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer
📍 Alaska Oncology and Hematology, LLC — Anchorage, Alaska
Carcinoma, Non-Small-Cell Lung
View Study & Checklist ➔Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma
📍 Dana Farber Cancer Institute — Boston, Massachusetts
Head and Neck Squamous Cell Carcinoma
View Study & Checklist ➔Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
📍 Providence Hospital — Mobile, Alabama
Neck Squamous Cell Carcinoma of Unknown Primary
View Study & Checklist ➔Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer
📍 Mayo Clinic Hospital in Arizona — Phoenix, Arizona
Clinical Stage I Esophageal Adenocarcinoma AJCC v8
View Study & Checklist ➔A Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)
📍 UC Davis — Sacramento, California
Non-Small Cell Lung Cancer
View Study & Checklist ➔A Phase III Study of Ceralasertib Plus Durvalumab Versus Docetaxel in Patients With Non Small Cell Lung Cancer (NSCLC) Whose Disease Progressed On or After Prior Anti PD (L)1 Therapy And Platinum Based Chemotherapy
📍 Research Site — Mobile, Alabama
Advanced or Metastatic Non-Small Cell Lung Cancer
View Study & Checklist ➔Efficacy Comparison of Cobolimab + Dostarlimab + Docetaxel to Dostarlimab + Docetaxel to Docetaxel Alone in Participants With Advanced Non-small Cell Lung Cancer Who Have Progressed on Prior Anti-PD-(L)1 Therapy and Chemotherapy
📍 GSK Investigational Site — Fountain Valley, California
Lung Cancer, Non-Small Cell
View Study & Checklist ➔A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies
📍 City of Hope National Medical Center — Duarte, California
Neoplasm Metastasis
View Study & Checklist ➔A Study of AB801 Monotherapy and Combination Therapy in Participants With Advanced Malignancies
📍 Research Site — Denver, Colorado
Advanced Cancer
View Study & Checklist ➔Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate
📍 UCLA / Jonsson Comprehensive Cancer Center — Los Angeles, California
Bladder Small Cell Neuroendocrine Carcinoma
View Study & Checklist ➔ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors
📍 XCancer/Dothan Hematology & Oncology - 1114 — Dothan, Alabama
Non Small Cell Lung Cancer
View Study & Checklist ➔Pembrolizumab/Placebo Plus Paclitaxel With or Without Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer (MK-3475-B96/KEYNOTE-B96/ENGOT-ov65).
📍 HonorHealth ( Site 0041) — Phoenix, Arizona
Ovarian Cancer
View Study & Checklist ➔Taxane and Taxane-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Anatomic Stage I Breast Cancer AJCC v8
View Study & Checklist ➔Study of Sacituzumab Govitecan (SG) Versus Docetaxel in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
📍 Alaska Oncology and Hematology, LLC. — Anchorage, Alaska
Non-Small Cell Lung Cancer
View Study & Checklist ➔Comparing the New Anti-cancer Drug Eribulin With Chemotherapy Against the Usual Chemotherapy Alone in Metastatic Urothelial Cancer
📍 Kingman Regional Medical Center — Kingman, Arizona
Metastatic Bladder Urothelial Carcinoma
View Study & Checklist ➔Adjuvant Treatment With Cisplatin-based Chemotherapy Plus Concomitant Atezolizumab in Patients With Stage I (Tumors ≥ 4cm), IIA, IIB, and Select Stage III [Any T1-3 N1-2 and T4N0-2] Resected Non-small Cell Lung Cancer (NSCLC) and the Clearance of Circulating Tumor DNA (ctDNA)
📍 Northwestern University Feinberg School of Medicine — Chicago, Illinois
Lung Cancer
View Study & Checklist ➔AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2
📍 Research Site — Mobile, Alabama
Gastric Cancer
View Study & Checklist ➔Adaptive Androgen Deprivation and Docetaxel in Metastatic Castration Sensitive Prostate Cancer
📍 Moffitt Caner Center — Tampa, Florida
Metastatic Castration Sensitive Prostate Cancer
View Study & Checklist ➔Combination Chemotherapy With or Without Trastuzumab in Treating Patients With Stage II or Stage III Breast Cancer
📍 City of Hope Medical Center — Duarte, California
Breast Cancer
View Study & Checklist ➔Testing the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus Pembrolizumab) Against the Usual Treatment for Advanced Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)
📍 Veterans Administration Medical Center - Birmingham — Birmingham, Alabama
Advanced Lung Non-Small Cell Carcinoma
View Study & Checklist ➔Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010]
📍 Highlands Oncology Group — Fayetteville, Arkansas
Non-Small Cell Lung Cancer
View Study & Checklist ➔Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC
📍 The University of Kansas Cancer Center - Clinical Research Center — Fairway, Kansas
Triple Negative Breast Cancer
View Study & Checklist ➔A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1).
📍 Urology Centers of Alabama — Homewood, Alabama
Metastatic Castrate Resistant Prostate Cancer (mCRPC)
View Study & Checklist ➔Cisplatin, Docetaxel, and Pembrolizumab in Treating Patients With Stage II-III Laryngeal Cancer
📍 M D Anderson Cancer Center — Houston, Texas
Laryngeal Squamous Cell Carcinoma
View Study & Checklist ➔Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) Cancer
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
Squamous Cell Carcinoma of the Head and Neck
View Study & Checklist ➔M6620 and Carboplatin With or Without Docetaxel in Treating Patients With Metastatic Castration-Resistant Prostate Cancer
📍 City of Hope Comprehensive Cancer Center — Duarte, California
Castration-Resistant Prostate Carcinoma
View Study & Checklist ➔Modern Immunotherapy in BCG-Unresponsive, BCG-Relapsing and High Risk BCG-Naive Non-Muscle Invasive Urothelial Carcinoma of the Bladder
📍 BCG Oncology — Phoenix, Arizona
Urothelial Carcinoma
View Study & Checklist ➔Study With Various Immunotherapy Treatments in Participants With Lung Cancer
📍 University of Alabama at Birmingham (UAB) — Birmingham, Alabama
Advanced Non-Small Cell Lung Cancer
View Study & Checklist ➔Ceritinib Plus Docetaxel in ALK-Negative, EGFR WT Advanced NSCLC
📍 Advent Health Orlando — Orlando, Florida
Non-small Cell Lung Cancer
View Study & Checklist ➔Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastroesophageal Junction (GEJ) Cancer
📍 Kaiser Permanente Dublin — Dublin, California
Clinical Stage I Gastric Cancer AJCC v8
View Study & Checklist ➔Neoadjuvant Carboplatin and Docetaxel in Triple Negative Breast Cancer
📍 TriHealth Hatton Research — Cincinnati, Ohio
Breast Cancer
View Study & Checklist ➔A Study of Zolbetuximab (IMAB362) in Adults With Gastric Cancer
📍 The Angeles Clinic and Research Institute — Los Angeles, California
Pharmacokinetics of Zolbetuximab
View Study & Checklist ➔Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors
📍 USC / Norris Comprehensive Cancer Center — Los Angeles, California
Head and Neck Squamous Cell Carcinoma
View Study & Checklist ➔Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery
📍 Providence Hospital — Mobile, Alabama
Lung Adenocarcinoma
View Study & Checklist ➔Gemcitabine, Docetaxel, and Hydroxychloroquine in Treating Participants With Recurrent or Refractory Osteosarcoma
📍 M D Anderson Cancer Center — Houston, Texas
Recurrent Osteosarcoma
View Study & Checklist ➔Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
📍 Anchorage Associates in Radiation Medicine — Anchorage, Alaska
Clear Cell Adenocarcinoma
View Study & Checklist ➔Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
📍 Providence Cancer Center — Anchorage, Alaska
Prostate Cancer
View Study & Checklist ➔Maintenance Chemotherapy With or Without Local Consolidative Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Recurrent Non-Small Cell Lung Carcinoma
View Study & Checklist ➔Neoadjuvant Intra-tumoral RP2 and FLOT in Gastroesophageal Adenocarcinoma
📍 Abramson Cancer Center at the University of Pennsylvania — Philadelphia, Pennsylvania
Gastric Adenocarcinoma
View Study & Checklist ➔A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma
📍 The University of Arizona Cancer Center — Tucson, Arizona
Oropharyngeal Carcinoma (OPC)
View Study & Checklist ➔RISK-ADAPT Protocol in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
📍 Georgetown University Medical Center- Lombardi Comprehensive Cancer Center — Washington D.C., District of Columbia
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
View Study & Checklist ➔De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA
📍 Mayo Clinic in Arizona — Scottsdale, Arizona
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
View Study & Checklist ➔Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma
📍 UT MD Anderson Cancer Center — Houston, Texas
Advanced Dedifferentiated Liposarcoma
View Study & Checklist ➔Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
📍 Research Site — Chandler, Arizona
Non-small Cell Lung Cancer (NSCLC)
View Study & Checklist ➔Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Metastatic Salivary Gland Carcinoma
View Study & Checklist ➔Toripalimab With Chemotherapy for Sinus Cancer
📍 Brigham and Women's Hospital — Boston, Massachusetts
Sinonasal Cancer
View Study & Checklist ➔Preoperative Pembrolizumab and Chemotherapy in Resectable, Recurrent HNSCC
📍 Brigham and Women's Hospital — Boston, Massachusetts
Head and Neck Squamous Cell Carcinoma
View Study & Checklist ➔Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
📍 UPMC Hillman Cancer Center - Radiation Oncology — Pittsburgh, Pennsylvania
Squamous Cell Carcinoma
View Study & Checklist ➔BRE-10: Biomarker Optimization of Neoadjuvant Therapy in Breast Cancer
📍 University of Illinois — Chicago, Illinois
Breast Cancer
View Study & Checklist ➔LUNG-05: Investigating Chemotherapy Effectiveness for Non-Small Cell Lung Cancer (NSCLC) Metastatic Patients
📍 University of Illinois Cancer Center — Chicago, Illinois
NSCLC
View Study & Checklist ➔A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
📍 Cancer Center at Saint Joseph's — Phoenix, Arizona
Locally Advanced Urothelial Carcinoma
View Study & Checklist ➔A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
📍 University of South Alabama, Mitchell Cancer Institute ( Site 6033) — Mobile, Alabama
Endometrial Cancer
View Study & Checklist ➔Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancer
📍 Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington
Anatomic Stage I Breast Cancer AJCC v8
View Study & Checklist ➔A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
📍 Arizona Clinical Trials — Chandler, Arizona
Prostatic Neoplasms, Castration-Resistant
View Study & Checklist ➔A Study of ASP1002 in Adults for Treatment of Solid Tumors
📍 Yale University Cancer Center — New Haven, Connecticut
Advanced Solid Tumors
View Study & Checklist ➔Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women With Stage I-III HER2 Negative Breast Cancer, the DOROTHY Trial
📍 City of Hope Medical Center — Duarte, California
Anatomic Stage I Breast Cancer AJCC v8
View Study & Checklist ➔Optimize Neoadjuvant Therapy in HER2-Positive Early-Stage Breast Cancer
📍 RWJBarnabas Health - Trinitas Hospital and Comprehensive Cancer Center — Elizabeth, New Jersey
HER2-positive Early-stage Breast Cancer
View Study & Checklist ➔A Study of ASP3082 in Adults With Advanced Solid Tumors
📍 City of Hope National Medical Center — Duarte, California
Solid Tumor
View Study & Checklist ➔A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
📍 Yale University School of Medicine — New Haven, Connecticut
Endometrial Cancer
View Study & Checklist ➔A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
📍 Mayo Clinic in Arizona - Phoenix ( Site 0044) — Phoenix, Arizona
Prostate Cancer
View Study & Checklist ➔Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer
📍 University of Kentucky Chandler Medical Center — Lexington, Kentucky
Non-Small Cell Lung Cancer
View Study & Checklist ➔A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer
📍 Florida Cancer Specialists — Sarasota, Florida
Metastatic Castration-resistant Prostate Neoplasms
View Study & Checklist ➔A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
📍 UCLA Hematology & Oncology ( Site 0003) — Los Angeles, California
Castration-Resistant Prostatic Cancer
View Study & Checklist ➔